Vanda Pharmaceuticals
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Vanda Pharmaceuticals
RECRUITINGPhase 4NCT05648591
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.
Sponsor: Vanda PharmaceuticalsEnrolling: 1009 locations
SchizophreniaBipolar I Disorder
RECRUITINGPhase 3NCT06961968
Randomized Withdrawal Study in Patients With Schizophrenia
The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in...
Sponsor: Vanda PharmaceuticalsEnrolling: 40020 locations
Schizophrenia